Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells
Toxins · 05.01.2023 · 15 (1) · 47
DOI: 10.3390/toxins15010047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, online erschienen am 05.01.2023. Verfasst von Sergei A Kozlovskiy und 7 weiteren Autor:innen. Beteiligte Einrichtung: G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, Vladivostok 690022, Russia. Hauptthemen laut MEDLINE: Naphthoquinones. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
P2X7 receptors are ligand-gated ion channels activated by ATP and play a significant role in cellular immunity. These receptors are considered as a potential therapeutic target for the treatment of multiple inflammatory diseases. In the present work, using spectrofluorimetry, spectrophotometry, Western blotting and ELISA approaches, the ability of 1,4-naphthoquinone thioglucoside derivatives, compounds U-286 and U-548, to inhibit inflammation induced by ATP/LPS in RAW 264.7 cells via P2X7 receptors was demonstrated. It has been established that the selected compounds were able to inhibit ATP-induced calcium influx and the production of reactive oxygen species, and they also exhibited pronounced antioxidant activity in mouse brain homogenate. In addition, compounds U-286 and U-548 decreased the LPS-induced activity of the COX-2 enzyme, the release of pro-inflammatory cytokines TNF-α and IL-1β in RAW 264.7 cells, and significantly protected macrophage cells against the toxic effects of ATP and LPS. This study highlights the use of 1,4-naphthoquinones as promising purinergic P2X7 receptor antagonists with anti-inflammatory activity. Based on the data obtained, studied synthetic 1,4-NQs can be considered as potential scaffolds for the development of new anti-inflammatory and analgesic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- G.B. Elyakov Pacific Institute of Bioorganic Chemistry, Far-Eastern Branch of the Russian Academy of Sciences, Vladivostok 690022, Russia.
ORCID-Profile: Sergei A Kozlovskiy, Evgeny A Pislyagin, Yuriy E Sabutski, Galina N Likhatskaya
Zitieren
APA
Kozlovskiy, S. A., Pislyagin, E. A., Menchinskaya, E. S., Chingizova, E. A., Sabutski, Y. E., Polonik, S. G., Likhatskaya, G. N., & Aminin, D. L. (2023). Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells. Toxins, 15(1), 47. https://doi.org/10.3390/toxins15010047
Vancouver
Kozlovskiy SA, Pislyagin EA, Menchinskaya ES, Chingizova EA, Sabutski YE, Polonik SG, et al. Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells. Toxins. 2023;15(1):47. doi:10.3390/toxins15010047
BibTeX
@article{Kozlovskiy2023,
author = {Kozlovskiy, Sergei A and Pislyagin, Evgeny A and Menchinskaya, Ekaterina S and Chingizova, Ekaterina A and Sabutski, Yuriy E and Polonik, Sergey G and Likhatskaya, Galina N and Aminin, Dmitry L},
title = {Anti-Inflammatory Activity of 1,4-Naphthoquinones Blocking P2X7 Purinergic Receptors in RAW 264.7 Macrophage Cells},
journal = {Toxins},
year = {2023},
volume = {15},
number = {1},
pages = {47},
doi = {10.3390/toxins15010047}
}
EUVIMED